Table 1.
Model | Advantages | Limitations |
---|---|---|
Genetically Engineered Mice [80,81,82] | Investigation of phenotypic consequences of GB progression (e.g., tissue invasion) | Lack of clinical validation Difficulties in reproducing human tumor heterogeneity Expensive and time consuming |
Mouse embryonic brains [47,48] | Feasibility to investigate immune interactions | Difficulties in assessing clinical relevance Technical issues due to in utero electroporation |
Human stem cells [83,84,85] | Possibility to investigate human GB onset Easiness in experimental standardization |
Absence of fundamental physiological components (e.g., immune and endothelial cells) |
Human cerebral organoids [46,77] | Assessment of human GB development, microenvironmental interactions in a 3D context Possibility to co-culture cancer cells with healthy neuronal cells |
Lack of fundamental physiological components (e.g., immune and endothelial cells) |